The fixed dose combination of abacavir and lamivudine tablets for oral suspension 60 mg/30 mg and 120 mg/60 mg is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents for pediatric patients.
What does ABC stand for?
ABC stands for Abacavir (aka Ziagen; GlaxoSmithKline)
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
- Business, finance, etc.
See other definitions of ABC
We have 1612 other meanings of ABC in our Acronym Attic
- Atari Bit Byter User Club
- American Black Book Writers Association
- Adirondack Boat Building and Water Skills School
- American Booksellers Book of the Year
- A Balanced Curriculum
- A Benihana Christmas (TV show)
- A Better Chance (organization)
- A Bittorrent Client (computing)
- A Business Community
- Aanvullend Beschermingscertificaat voor Geneesmiddelen (Dutch: supplementary protection certificate for medicinal products)
- Abbott Bioresearch Center (Massachusetts)
- Abbreviated Blood Count
- ABC Conjecture (problem in pure mathematics)
- Aberdeen Boat Club (Hong Kong)
- Abilene Community Band (Abilene, TX)
- Aboriginal Business Canada (Canadian government)
- Abrasive Blasting & Coating, Inc.
- Absolute Band Count
- Absolute Basophil Count
- Absolute Brain Control
Samples in periodicals archive:
The fixed dose combination of abacavir and lamivudine tablets for oral suspension 60 mg/30 mg and 120 mg/60 mg is indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents for paediatric patients.
No association of abacavir use with risk of myocardial infarction or severe cardiovascular disease events: results from ACTG A5001.
Abacavir is sold by GlaxoSmithKline under the brand name Ziagen, but it is also an ingredient in Kivexa and Trizivir.
A study in Australia showed that a genetic test was very effective in predicting which patient would react badly to abacavir (Ziagen) [1,2].
Cipla (India), Ranbaxy (India), Strides Arcolab (India) and Aspen Pharmacare (South Africa)- relying on supply of active pharmaceutical ingredients from Matrix Laboratories (India)-will offer the ARV efavirenz for $240 per patient per year, and Cipla will offer the ARV abacavir for $447.
Each day, half the volunteers received one pill containing efavirenz and another containing abacavir and lamivudine.
At the heart of the dispute is a researcher who, the institution says, invented the Aids drug Ziagen, known generically as abacavir.